Previous close | 29.05 |
Open | 13.20 |
Bid | 14.50 |
Ask | 18.90 |
Strike | 70.00 |
Expiry date | 2024-09-20 |
Day's range | 13.20 - 29.05 |
Contract range | N/A |
Volume | |
Open interest | 3 |
On May 29, 2024, Stewart Strong, President of Global Hospital at Haemonetics Corp (NYSE:HAE), sold 8,857 shares of the company.
On May 29, 2024, Michelle Basil, Executive Vice President and General Counsel of Haemonetics Corp (NYSE:HAE), executed a sale of 12,990 shares of the company at a price of $88.08 per share.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.